Three gadolinium-labeled compounds, potential nuclear magnetic resonance (hTlR) imaging contrast agents for liver and biliary tract, were studied: I ) Gd-DISIDA, 2 ) Gd-DTPA-Liposomes, and 3 ) Gd-DTPA dihexadecylamide (Gd-diamide). In each case, "Carrier Added" Gd-153 with specific activity of about
Gadolinium-labeled liposomes containing paramagnetic amphipathic agents: Targeted MRI contrast agents for the liver
โ Scribed by G. W. Kabalka; E. Buonocore; K. Hubner; M. Davis; L. Huang
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 430 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
โฆ Synopsis
Unique paramagnetic liposomal contrast agents were synthesized and utilized for selective augmentation of TI MR imaging of the livers of normal Balb/c mice. Amphipathic gadolinium complexes, which mimic phospholipids, were incorporated into the lamella of small unilamellar liposomes (SUV) such that they became an integral part of its surface. T 1 signal enhancement of normal liver approached 150% after iv administration of the paramagnetic liposomes, determined by experiments performed on a 1.9-T, experimental whole-body MRI unit. Tracer studies utilizing gadolinium-153-tagged SUV revealed that the agents exhibited excellent in vivo stability, compared to liposomal preparations in which paramagnetic agents are simply entrapped in the aqueous core of the IipOSOme vesicle.
๐ SIMILAR VOLUMES